MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Döhr, O.
Right arrow Articles by Abel, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Döhr, O.
Right arrow Articles by Abel, J.

0026-895X/97/050703-08$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:703-710 (1997).

Effect of Transforming Growth Factor-beta 1 on Expression of Aryl Hydrocarbon Receptor and Genes of Ah Gene Battery: Clues for Independent Down-Regulation in A549 Cells

Olaf Döhr, Ralf Sinning, Christoph Vogel, Peter Münzel, and Josef Abel

Medical Institute of Environmental Hygiene, Heinrich-Heine-University of Düsseldorf, Department of Toxicology, 40225 Düsseldorf, Germany (O.D., R.S., C.V., J.A.), and Institute of Toxicology, University of Tübingen, Wilhelmstrabeta e 56, 72074 Tübingen, Germany (P.M.)

An inhibitory effect on both constitutive and inducible expression of cytochrome P450 isoenzymes has been shown for different cytokines and growth factors. We previously described an inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced CYP1A1 mRNA and enzyme activity by transforming growth factor-beta 1 (TGF-beta 1) in human lung cancer A549 cells. In the present study, we report that not only TCDD-induced expression of CYP1A1 but also basal mRNA expression of CYP1A1, CYP1B1, and aryl hydrocarbon receptor (AHR) was down-regulated by TGF-beta 1 in cells not treated with TCDD. In contrast, mRNA expression of the AHR partner protein Arnt (aryl hydrocarbon receptor nuclear translocator) was not influenced. Furthermore, TCDD-induced expression of CYP1B1 and NMO-1 was inhibited, and the IC50 values of 5-10 pM TGF-beta 1 were in the same range as observed for inhibition of CYP1A1 and AHR mRNA expression. Transfection studies with a plasmid containing a luciferase reporter gene under control of two dioxin-responsive elements indicate an effect on AHR protein expression. Results of time-course studies revealed a parallel inhibition of AHR and CYP1 mRNA expression, indicating that TGF-beta 1 is a direct negative regulator of transcription of these genes. The treatment of cells with cycloheximide led to a superinduction of TCDD-induced CYP1A1 and CYP1B1 mRNA expression and abolished the inhibitory effect of TGF-beta 1 on basal as well as TCDD-induced CYP1 and AHR mRNA expression. TGF-beta 1 seems not to influence the stability of AHR mRNA. The results suggest that TGF-beta 1 induces rapid transcription and translation of an as-yet-unknown negative regulatory factor or factors that may directly regulate expression of AHR and genes of Ah gene battery.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
X. Chang, Y. Fan, S. Karyala, S. Schwemberger, C. R. Tomlinson, M. A. Sartor, and A. Puga
Ligand-Independent Regulation of Transforming Growth Factor {beta}1 Expression and Cell Cycle Progression by the Aryl Hydrocarbon Receptor
Mol. Cell. Biol., September 1, 2007; 27(17): 6127 - 6139.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
F Gadal, A Starzec, C Bozic, C Pillot-Brochet, S Malinge, V Ozanne, J Vicenzi, L Buffat, G Perret, F Iris, et al.
Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells
J. Mol. Endocrinol., February 1, 2005; 34(1): 61 - 75.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. Santiago-Josefat, S. Mulero-Navarro, S. L. Dallas, and P. M. Fernandez-Salguero
Overexpression of latent transforming growth factor-{beta} binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts
J. Cell Sci., February 22, 2004; 117(6): 849 - 859.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Wolff, P. A. Harper, J. M. Y. Wong, V. Mostert, Y. Wang, and J. Abel
Cell-Specific Regulation of Human Aryl Hydrocarbon Receptor Expression by Transforming Growth Factor-{beta}1
Mol. Pharmacol., April 1, 2001; 59(4): 716 - 724.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
C. Vogel, A.-M. J.F. Boerboom, C. Baechle, C. El-Bahay, R. Kahl, G. H. Degen, and J. Abel
Regulation of prostaglandin endoperoxide H synthase-2 induction by dioxin in rat hepatocytes: possible c-Src-mediated pathway
Carcinogenesis, December 1, 2000; 21(12): 2267 - 2274.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. S. Thurmond and T. A. Gasiewicz
A Single Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Produces a Time- and Dose-Dependent Alteration in the Murine Bone Marrow B-Lymphocyte Maturation Profile
Toxicol. Sci., November 1, 2000; 58(1): 88 - 95.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Hukkanen, A. Lassila, K. Päivärinta, S. Valanne, S. Sarpo, J. Hakkola, O. Pelkonen, and H. Raunio
Induction and Regulation of Xenobiotic-Metabolizing Cytochrome P450s in the Human A549 Lung Adenocarcinoma Cell Line
Am. J. Respir. Cell Mol. Biol., March 1, 2000; 22(3): 360 - 366.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
F. J. Gonzalez and P. Fernandez-Salguero
The Aryl Hydrocarbon Receptor. Studies Using the AHR-Null Mice
Drug Metab. Dispos., December 1, 1998; 26(12): 1194 - 1198.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
H. Iber and E. T. Morgan
Regulation of Hepatic Cytochrome P450 2C11 by Transforming Growth Factor-beta , Hepatocyte Growth Factor, and Interleukin-11
Drug Metab. Dispos., October 1, 1998; 26(10): 1042 - 1044.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics